2022 annual financial data
Radiopharm Theranostics 2022 Net margin
Direct answer
Net margin was -343,550.89%.
Operating income was -19,916,352 AUD and net income was -30,338,979 AUD.
Operating cash flow was -9,915,654 AUD.
Get free Radiopharm Theranostics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 8,831 AUD
- Operating income
- -19,916,352 AUD
- Net income
- -30,338,979 AUD
- Operating cash flow
- -9,915,654 AUD
Explore related company data
View all 2022 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all Radiopharm Theranostics financial years